Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Effects of the illegal use of pharmaceutical products in animal production on human health

13.09.2002


The use of drugs/pharmaceuticals in cattle rearing is the object of a recent study, carried out by two researchers from the Centro de Estudos Farmacêuticos, Laboratório de Bromatologia, Hidrologia e Nutrição (Pharmaceutical Study Centre, Bromatology, Hydrology and Nutrition Laboratory) at the Pharmacy Faculty of Coimbra University. The consequences for consumers are, from a public health standpoint, the most significant conclusions to take from an exhaustive work of literary revision in these matters, started in 2000.



The fat content contained in the meat has been a concern for consumers, for reasons of health and diet, who consider it an unnecessary nutrient, or rather, best avoided. For this reason producers attempt to improve the return on their activities by producing more and better lean meat, and in the shortest possible space of time. In this context, the quantity of drugs/ pharmaceuticals used to promote animal growth has been increasing exponentially, especially connected to forms of intensive methods of farming, which has meant an increase in the availability of foods, but in the meanwhile it has also meant the presence of the residues of these products in not insignificant levels in meat.

The researchers Fernando Ramos and Maria Irene Noronha da Silveira have dedicated themselves to the study of the use of a group of pharmaceuticals known as andrenergic agonists b2. Part of the work of the authors – published in the Revista Portuguesa de Ciências Veterinárias (Portuguese Veterinary Science Magazine) in the Summer of 2002 – concentrates on the use of those substances in the average daily weight increase of chickens, swine, sheep and bovines, specifically the increase in muscle mass and the decrease of body fat. In fact, the andrenergic agonists b2 facilitate the production of leaner meat, but not without consequences, be it at a zootechny level, be it at levels of toxins for consumers. There have already been three cases of poisoning of groups of people in Portugal, between 1998 and 2001, and similar situations occurred in Spain, France and Italy in the last decade.


Of this group of pharmaceuticals, only one is authorised for therapeutic ends in veterinary medicine. Its use is prohibited in zootechny. The proliferation of the illegal use of veterinary medicines in general, and andrenergic agonists b2 in particular, raises concerns regarding toxicity, especially for consumers but also for cattle-feeders. The danger of toxicity in the animal can be controlled, as long as good veterinary and agricultural practice is maintained; regarding the environment, these products do not present eco-toxicity, as their elimination in faeces has no bad effects on the quality of soil or water.
Regarding the cattle-feeder, people who suffer from illnesses related with the cardio-respiratory system, like asthmatics, are advised not to work in this area. If norms of security and hygiene at work are not respected there is also the danger of dermatological and pulmonary problems.

With regard to the consumer, the main toxic effects of the pharmaceuticals are a reflection of the exaggerated pharmacological responses due to the administration of large doses , that leave residues in the edible tissue of meat-producing animals. The monitoring of these parameters is particularly important taking into account the risk-populations that are made up of individuals that suffer from isquemic cardiopathy, high blood pressure and/or those who have hydro-electrolytic problems. The problem extends to those who need to take diuretics and all those who are being treated with pharmaceuticals from the same therapeutic group, which are in general, people who suffer from asthmatic problems to a greater or lesser degree, and that represent a considerable proportion of the world population (10% in 1995).

Although the diagnosis of intoxication by andrenergic agonists b2 is extremely difficult in an isolated patient, the authors believe the chance of intoxication should be seriously taken into account when the corresponding symptomatology occurs in a group of people who have eaten liver – this being the edible tissue where the pharmaceuticals in question accumulate in the greatest quantity and for longer.

The authors suggest that in cases of intoxication – like those registered in Portugal – that the sanitary authority is alerted, namely the new Agência para a Qualidade e Segurança Alimentar (Agency for Food Quality and Security). If it is possible to analyse the foods in question, efforts should be made to identify the butcher that sold the meat, the slaughterhouse and the producer, in order to be able to act against those responsible for crime of Public Health.

Fernando Ramos | alfa
Further information:
http://rpcv.fmv.utl.pt/edicao/6_2002/502_51_62.htm

More articles from Health and Medicine:

nachricht Nitric oxide-scavenging hydrogel developed for rheumatoid arthritis treatment
06.06.2019 | Pohang University of Science & Technology (POSTECH)

nachricht Infants later diagnosed with autism follow adults’ gaze, but seldom initiate joint attention
24.05.2019 | Schwedischer Forschungsrat - The Swedish Research Council

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: MPSD team discovers light-induced ferroelectricity in strontium titanate

Light can be used not only to measure materials’ properties, but also to change them. Especially interesting are those cases in which the function of a material can be modified, such as its ability to conduct electricity or to store information in its magnetic state. A team led by Andrea Cavalleri from the Max Planck Institute for the Structure and Dynamics of Matter in Hamburg used terahertz frequency light pulses to transform a non-ferroelectric material into a ferroelectric one.

Ferroelectricity is a state in which the constituent lattice “looks” in one specific direction, forming a macroscopic electrical polarisation. The ability to...

Im Focus: Determining the Earth’s gravity field more accurately than ever before

Researchers at TU Graz calculate the most accurate gravity field determination of the Earth using 1.16 billion satellite measurements. This yields valuable knowledge for climate research.

The Earth’s gravity fluctuates from place to place. Geodesists use this phenomenon to observe geodynamic and climatological processes. Using...

Im Focus: Tube anemone has the largest animal mitochondrial genome ever sequenced

Discovery by Brazilian and US researchers could change the classification of two species, which appear more akin to jellyfish than was thought.

The tube anemone Isarachnanthus nocturnus is only 15 cm long but has the largest mitochondrial genome of any animal sequenced to date, with 80,923 base pairs....

Im Focus: Tiny light box opens new doors into the nanoworld

Researchers at Chalmers University of Technology, Sweden, have discovered a completely new way of capturing, amplifying and linking light to matter at the nanolevel. Using a tiny box, built from stacked atomically thin material, they have succeeded in creating a type of feedback loop in which light and matter become one. The discovery, which was recently published in Nature Nanotechnology, opens up new possibilities in the world of nanophotonics.

Photonics is concerned with various means of using light. Fibre-optic communication is an example of photonics, as is the technology behind photodetectors and...

Im Focus: Cost-effective and individualized advanced electronic packaging in small batches now available

Fraunhofer IZM is joining the EUROPRACTICE IC Service platform. Together, the partners are making fan-out wafer level packaging (FOWLP) for electronic devices available and affordable even in small batches – and thus of interest to research institutes, universities, and SMEs. Costs can be significantly reduced by up to ten customers implementing individual fan-out wafer level packaging for their ICs or other components on a multi-project wafer. The target group includes any organization that does not produce in large quantities, but requires prototypes.

Research always means trying things out and daring to do new things. Research institutes, universities, and SMEs do not produce in large batches, but rather...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

SEMANTiCS 2019 brings together industry leaders and data scientists in Karlsruhe

29.04.2019 | Event News

Revered mathematicians and computer scientists converge with 200 young researchers in Heidelberg!

17.04.2019 | Event News

First dust conference in the Central Asian part of the earth’s dust belt

15.04.2019 | Event News

 
Latest News

A new paradigm of material identification based on graph theory

17.06.2019 | Materials Sciences

Electron beam strengthens recyclable nanocomposite

17.06.2019 | Materials Sciences

Tiny probe that senses deep in the lung set to shed light on disease

17.06.2019 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>